Shanxi Zhendong Pharmaceutical Co.,Ltd
300158.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.27B
Close$
Share Statistics
| Market cap | $5.27 Billion |
|---|---|
| Enterprise Value | $5.30 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.3 |
| Beta | 0.19 |
| Outstanding Shares | 992,303,056 |
Return
| Return on Equity | -12.34% |
|---|---|
| Return on Assets | -9.40% |
| Return on Invested Capital | -12.04% |
Valuation & Multiples
| P/E Ratio | -13.27 |
|---|---|
| PEG | 0.91 |
| Price to Sales | 2.55 |
| Price to Book Ratio | 1.7 |
| Enterprise Value to Revenue | 2.19 |
| Enterprise Value to EBIT | -13.33 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanxi Zhendong Pharmaceutical Co.,Ltd
3,695 employees
CEO: Yong Hua Chen Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, dige...